DK0943331T3 - Formuleringer indeholdende oxaliplatin - Google Patents

Formuleringer indeholdende oxaliplatin

Info

Publication number
DK0943331T3
DK0943331T3 DK99301412T DK99301412T DK0943331T3 DK 0943331 T3 DK0943331 T3 DK 0943331T3 DK 99301412 T DK99301412 T DK 99301412T DK 99301412 T DK99301412 T DK 99301412T DK 0943331 T3 DK0943331 T3 DK 0943331T3
Authority
DK
Denmark
Prior art keywords
formulations containing
containing oxaliplatin
oxaliplatin
formulations
Prior art date
Application number
DK99301412T
Other languages
Danish (da)
English (en)
Inventor
Nicholas H Anderson
Ross Blundell
Stephen Brown
David A England
Martin R Gray
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10827600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0943331(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0943331T3 publication Critical patent/DK0943331T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99301412T 1998-02-25 1999-02-25 Formuleringer indeholdende oxaliplatin DK0943331T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804013.2A GB9804013D0 (en) 1998-02-25 1998-02-25 Formulations

Publications (1)

Publication Number Publication Date
DK0943331T3 true DK0943331T3 (da) 2001-10-15

Family

ID=10827600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99301412T DK0943331T3 (da) 1998-02-25 1999-02-25 Formuleringer indeholdende oxaliplatin

Country Status (28)

Country Link
US (1) US6306902B1 (fr)
EP (1) EP0943331B1 (fr)
JP (1) JP4430229B2 (fr)
KR (1) KR20010041182A (fr)
CN (1) CN1152718C (fr)
AR (1) AR015524A1 (fr)
AT (1) ATE202472T1 (fr)
AU (1) AU757101B2 (fr)
BR (1) BR9908273A (fr)
CA (1) CA2261500C (fr)
CZ (1) CZ302196B6 (fr)
DE (1) DE69900162T2 (fr)
DK (1) DK0943331T3 (fr)
ES (1) ES2161085T3 (fr)
GB (1) GB9804013D0 (fr)
GR (1) GR3036646T3 (fr)
GT (1) GT199900019A (fr)
HK (1) HK1036405A1 (fr)
HU (1) HU224611B1 (fr)
IL (1) IL137772A (fr)
MX (1) MXPA00008195A (fr)
NO (1) NO329900B1 (fr)
PL (1) PL197948B1 (fr)
PT (1) PT943331E (fr)
RU (1) RU2207857C2 (fr)
UA (1) UA70316C2 (fr)
WO (1) WO1999043355A2 (fr)
ZA (1) ZA991489B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
AU762138B2 (en) * 1998-10-14 2003-06-19 Debiopharm S.A. Oxaliplatinum preparation packaging
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
BRPI0013613B8 (pt) * 1999-08-30 2021-05-25 Debiopharm Sa composição farmacêuticamente estável de oxaliplatina para administração parenteral.
US7012072B2 (en) * 2000-12-12 2006-03-14 Debiopharm S.A. Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
EP1368022B1 (fr) 2001-03-02 2007-06-20 Debiopharm S.A. Utilisation d'un flacon contenant une solution d'oxaliplatine
WO2003004505A1 (fr) 2001-07-02 2003-01-16 Debiopharm S.A. Substance active a base d'oxaliplatine presentant une faible teneur en acide oxalique
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (fr) * 2002-05-31 2003-11-30 Voiceage Corporation Methode et dispositif pour l'amelioration selective en frequence de la hauteur de la parole synthetisee
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
WO2005020980A1 (fr) * 2003-08-28 2005-03-10 Mayne Pharma Pty Ltd Formulations d'oxaliplatine contenant de l'acide
GB2441445B (en) * 2003-08-28 2008-04-23 Mayne Pharma Ltd Acid containing oxaliplatin formulation
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
JP2007512318A (ja) 2003-11-25 2007-05-17 プラトコ・テクノロジーズ・（プロプライエタリー）・リミテッド 白金（ｉｉ）錯体並びに該錯体の製法及び使用
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
WO2005102312A1 (fr) * 2004-04-27 2005-11-03 Mayne Pharma Limited Solutions concentrees d'oxaliplatine
CN101018797A (zh) 2004-09-01 2007-08-15 普拉托技术（私有）有限公司 铂(ⅱ)配合物的制备
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
CA2604862A1 (fr) * 2005-04-09 2006-10-19 Vuab Pharma A.S. Procede de realisation d'une preparation a base d'oxalyplatine
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (fr) * 2005-09-05 2007-03-15 Dabur Pharma Limited Formulation stable d'oxaliplatine
KR20080096682A (ko) 2006-01-30 2008-10-31 플라트코 테크놀로지스 (프로프라이어터리) 리미티드 백금(ⅱ) 착물의 제조법
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
MX2009007801A (es) * 2007-01-22 2009-10-08 Pliva Lachema As Composicion farmaceutica de oxaliplatino con regulador basado en azucar alcoholico.
WO2009087660A1 (fr) * 2007-11-12 2009-07-16 Intas Pharmaceuticals Limited Composition d'oxaliplatine stable pour une administration parentérale
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
WO2010056847A2 (fr) * 2008-11-13 2010-05-20 Taigen Biotechnology Co., Ltd. Formule lyophilisée
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
JP5759464B2 (ja) 2009-09-21 2015-08-05 ジェイダブリュー ファーマシューティカル コーポレイション オキサリプラチンのナノ粒子及びその製造方法
CN102274171A (zh) * 2011-08-04 2011-12-14 上海希迪制药有限公司 一种奥沙利铂注射剂
CN104523674B (zh) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 一种以奥沙利铂为主药成分的注射用组合物
KR101683635B1 (ko) * 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN104829653B (zh) * 2015-05-06 2016-03-23 山东罗欣药业集团股份有限公司 一种奥沙利铂水合物晶体及其冻干粉针剂
US10751365B2 (en) 2018-01-12 2020-08-25 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
PT93772A (pt) 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
EP0464210A4 (en) 1989-12-15 1992-11-25 Tsumura & Co. Novel platinum complex and antitumor drug containing the same as active ingredient
JPH04185601A (ja) 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
AU671605B2 (en) 1991-11-15 1996-09-05 Smithkline Beecham Corporation Combination chemotherapy
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JPH05238936A (ja) 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
AU5416394A (en) * 1992-11-24 1994-06-22 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
JP3025602B2 (ja) * 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
KR100365171B1 (ko) 1994-08-08 2003-02-19 드바이오팜 에스.아. 약학적으로안정한옥살리플라티늄제제
DE69531722T2 (de) * 1994-11-11 2004-07-01 Debiopharm S.A. Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
EP0801070B1 (fr) 1996-04-10 2003-04-16 Debiopharm S.A. Procédé de préparation de composés du platine
JPH09294809A (ja) 1996-05-07 1997-11-18 Terumo Corp 薬液注入器具
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations

Also Published As

Publication number Publication date
AR015524A1 (es) 2001-05-02
CA2261500A1 (fr) 1999-08-25
CZ302196B6 (cs) 2010-12-15
IL137772A (en) 2006-04-10
DE69900162T2 (de) 2002-04-18
JP4430229B2 (ja) 2010-03-10
EP0943331A2 (fr) 1999-09-22
GB9804013D0 (en) 1998-04-22
MXPA00008195A (es) 2004-11-22
JP2002504524A (ja) 2002-02-12
US6306902B1 (en) 2001-10-23
NO20004240L (no) 2000-10-18
WO1999043355A2 (fr) 1999-09-02
HK1036405A1 (en) 2002-01-04
UA70316C2 (uk) 2004-10-15
EP0943331A3 (fr) 1999-11-03
CN1291886A (zh) 2001-04-18
CA2261500C (fr) 2001-07-17
CN1152718C (zh) 2004-06-09
WO1999043355A3 (fr) 1999-11-04
RU2207857C2 (ru) 2003-07-10
PT943331E (pt) 2001-12-28
DE69900162D1 (de) 2001-08-02
NO329900B1 (no) 2011-01-24
NO20004240D0 (no) 2000-08-24
GR3036646T3 (en) 2001-12-31
HUP0103707A2 (hu) 2002-02-28
PL197948B1 (pl) 2008-05-30
ATE202472T1 (de) 2001-07-15
ES2161085T3 (es) 2001-11-16
AU2632499A (en) 1999-09-15
PL343021A1 (en) 2001-07-30
ZA991489B (en) 1999-09-30
CZ20003089A3 (cs) 2000-12-13
HUP0103707A3 (en) 2004-07-28
AU757101B2 (en) 2003-01-30
EP0943331B1 (fr) 2001-06-27
GT199900019A (es) 2000-08-04
BR9908273A (pt) 2000-10-24
HU224611B1 (hu) 2005-11-28
KR20010041182A (ko) 2001-05-15

Similar Documents

Publication Publication Date Title
DK0943331T3 (da) Formuleringer indeholdende oxaliplatin
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
ATE224703T1 (de) Brauseformulierungen
DE69937339D1 (de) Bakterizide
DE69904058D1 (de) Glyphosat-formulierung
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID26549A (id) Komposisi-komposisi epotilon
PT1130966E (pt) Formulacoes antiparasitarias
ATE367793T1 (de) Schweisshemmende zusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
ID29635A (id) Formulasi mikrokapsul
ID29430A (id) Komposisi herbisida
MA24473A1 (fr) Formulations
ID23458A (id) Bentuk sediaan nefazodon
DE69935172D1 (de) Imidosilan Zusammensetzungen
DE69838290D1 (de) Vernetzungszusammensetzungen
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
ID27655A (id) Formulasi mikrokapsul